discovermagazine - Learn how severe respiratory illness leaves the lungs vulnerable to cancer, and how vaccines could prevent these vulnerabilities.
AI Summary: New animal and observational evidence suggests severe respiratory infections—including serious COVID‑19 and influenza—can prime lung tissue and accelerate cancer development months to years later. Vaccination appeared to blunt those effects in experimental models, highlighting prevention as a potential cancer‑risk reduction strategy and urging clinicians to watch survivors of severe infections more closely.
Liquid biopsy may speed childhood Burkitt lymphoma diagnosis in Africa / 3 months
Shingles vaccine linked to nearly halved risk of serious cardiac events / 3 months
Personalized cessation program doubles quit rates for cervical cancer survivors / 3 months
Jeremy Clarkson treated for aggressive prostate cancer, now in remission / 16 days
Countdown to Brachytherapy Awareness Day spotlights the specialty / 20 days
More Americans survive cancer but mental health challenges persist / 20 days
HPV vaccine dramatically reduces cervical cancer deaths in young women / 22 days
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.